ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990

House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention

July 20, 1990

NCAB Approves 8 Cancer Centers As Comprehensive

October 4, 1991

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

DCCP To Have Board Of Scientific Counselors

September 1, 1978

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004